Revelation Capital Management as of June 30, 2022
Portfolio Holdings for Revelation Capital Management
Revelation Capital Management holds 3 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Singular Genomics Systems In | 76.5 | $5.4M | 1.4M | 3.82 | |
| Neuropace (NPCE) | 17.4 | $1.2M | 248k | 4.95 | |
| Accolade (ACCD) | 6.1 | $430k | 58k | 7.41 |
